Top by categoryEvery category ranked by need: services, software and firms.
Top software by featureThe best tools for one job, across every software category.
Top companies by countryThe leading B2B firms in each country, category by category.
Popular software rankings
Top Inventory Management Software
Top Supplier Management Software
Top Fleet Management Software
Top Cloud Storage Backup Software
Top Master Data Management Software
Top Document Storage Software
Top 3D Modeling Software
Top Compliance Tracking Software
See all popular software rankings
Popular category rankings
Top Software Development Companies
Top Digital Marketing Companies
Top App Development Companies
Top Web Design Agencies
Top Accounting Firms
Top Recruitment Agencies
Top Advertising Companies
Top Design Agencies
See all popular category rankings
Top companies by country
Top companies in the UK
Top companies in the USA
Top companies in India
Top companies in Canada
Top companies in Australia
Top companies in Germany
Top companies in the UAE
Top companies in Pakistan
See all top companies by country
All rankings All categories How we rank

Investor

Adjuvant Capital

Investment firm funding life science technologies that address major global health challenges

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

Adjuvant Capital cover

About Adjuvant Capital

Adjuvant Capital is an investment firm that finances medical technologies aimed at public health problems that have drawn little commercial attention. It says its aim is to make promising products reach the people who need them most.

What Adjuvant Capital offers

Infectious disease investment — backing for work on HIV/AIDS, tuberculosis and malaria, tropical diseases such as schistosomiasis, pandemic threats such as MERS and Lassa fever, and antimicrobial resistance.
Maternal and child health — funding for technologies in this area.
Reproductive and sexual health — investment in products for these needs.
Commercialisation focus — most activity centres on technologies already shown to be safe and effective in people, with the goal of speeding up availability.

Who it works with

Developers of life science technologies for underserved markets, including emerging economies. The firm itself is backed by strategic investors and alternative asset managers.

Profile written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images — click to enlarge

Categories & features

Rankings

As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to Adjuvant Capital

Reviews

Write the first review of Adjuvant Capital

Used it? Your experience helps other buyers decide.

Questions & answers

No questions yet. Be the first to ask about Adjuvant Capital.

Adjuvant Capital alternatives

Similar listings buyers compare against this one.

Compare side by side

Expa

Company studio and early-stage investor that designs, builds and funds startups with hands-on founder support

Compare

Boston Scientific

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Compare

Techstars

Global startup accelerator and early-stage investor running city and sector programmes for founders

Compare

Kleiner Perkins Caufield & Byers

Silicon Valley venture capital firm that has backed well-known technology companies since their early stages

Compare

Insight Partners

Global software investor backing growth-stage technology companies with capital and in-house operating specialists

Compare

Alsop Louie Partners

San Francisco early-stage technology venture firm led by two founding partners with a stated humane-technology outlook

Compare

Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.